Browse by Tags
All Tags »
Clin Cancer Res (
RSS)
Sorry, but there are no more tags available to filter with.
-
|
Related Articles Histone Deacetylase 8 in Neuroblastoma Tumorigenesis. Clin Cancer Res. 2009 Jan 1;15(1):91-99 Authors: Oehme I, Deubzer HE, Wegener D, Pickert D, Linke JP, Hero B, Kopp-Schneider A, Westermann F, Ulrich SM, von Deimling A, Fischer M,...
|
-
|
Related Articles Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells. Clin Cancer Res. 2008 Dec 1;14(23):7711-6 Authors: Farrell CJ, Zaupa C, Barnard Z, Maley J,...
|
-
|
Related Articles Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma. Clin Cancer Res. 2008 Nov 15;14(22):7223-36 Authors: Rouleau C, Curiel M, Weber W, Smale R, Kurtzberg L, Mascarello J, Berger...
|
-
|
Related Articles Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal Doxorubicin. Clin Cancer Res. 2008 Nov 15;14(22):7320-9 Authors: Pastorino F, Di Paolo D, Piccardi F, Nico B, Ribatti D, Daga A, Baio G, Neumaier CE, Brignole...
|
-
|
Related Articles Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma. Clin Cancer Res. 2008 Nov 1;14(21):7011-9 Authors: Yagyu S, Gotoh T, Iehara T, Miyachi M...
|
-
|
Related Articles Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma. Clin Cancer Res. 2008 Nov 1;14(21):7020-7 Authors: Cheung IY, Feng Y, Gerald W, Cheung NK PURPOSE: Minimal residual disease (MRD...
|
-
|
Related Articles Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma. Clin Cancer Res. 2008 Nov 1;14(21):7028-34 Authors: Egler RA, Burlingame SM, Nuchtern JG, Russell HV PURPOSE: To explore...
|
-
|
Related Articles Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins. Clin Cancer Res. 2008 Oct 15;14(20):6531-7 Authors: Michaelis M, Bliss...
|
-
|
Related Articles Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR. Clin Cancer Res. 2008 Oct 15;14(20):6590-6601 Authors: Oberthuer A, Kaderali L, Kahlert Y, Hero B, Westermann...
|
-
|
Related Articles Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis. Clin Cancer Res. 2008 Oct 1;14(19):6237-45 Authors: Hsu WM, Lee H, Juan HF, Shih YY, Wang BJ, Pan CY, Jeng YM, Chang HH,...
|
-
|
Related Articles Whole Chromosome Alterations Predict Survival in High-Risk Neuroblastoma without MYCN Amplification. Clin Cancer Res. 2008 Sep 1;14(17):5540-7 Authors: Bilke S, Chen QR, Wei JS, Khan J PURPOSE: Patients with stage IV neuroblastoma over...
|
-
|
Related Articles Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models. Clin Cancer Res. 2008 Jul 15;14(14):4622-30 Authors: Vitali R, Mancini C, Cesi V, Tanno B, Mancuso...
|